Top 4 Health Care Stocks That May Rocket Higher In Q1
Top 4 Health Care Stocks That May Rocket Higher In Q1
The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.
医疗保健领域超卖最多的股票为买入被低估的公司提供了机会。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI 是一种动量指标，它比较股票在价格上涨的日子和价格下跌的日子的走势。与股票的价格走势相比，它可以让交易者更好地了解股票在短期内的表现。根据Benzinga Pro的数据，当相对强弱指数低于30时，资产通常被视为超卖。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是该行业主要超卖参与者的最新名单，其相对强弱指数接近或低于30。
iBio, Inc. (NYSE:IBIO)
iBio, Inc.（纽约证券交易所代码：IBIO）
- On Dec. 5, iBio announced pricing of a $4.5 million public offering. The company's stock fell around 11% over the past five days and has a 52-week low of $1.16 .
- RSI Value: 23.25
- IBIO Price Action: Shares of iBio fell 4.9% to close at $1.17 on Friday.
- 12月5日，iBio宣布了450万美元公开募股的定价。该公司的股票在过去五天中下跌了约11％，并且 52 周低点为 1.16 美元 。
- RSI 值：23.25
- IBIO价格走势：周五，iBio的股价下跌4.9％，收于1.17美元。
GRI Bio, Inc. (NASDAQ:GRI)
GRI Bio, Inc.（纳斯达克股票代码：GRI）
- On Dec. 5, the company announced the initiation of patient enrollment in the Phase 2a biomarker study evaluating GRI-0621 for the treatment of IPF. The company's stock fell around 23% over the past month. It has a 52-week low of $0.2838.
- RSI Value: 27.58
- GRI Price Action: Shares of GRI Bio fell 3% to close at $0.3152 on Friday.
- 12月5日，该公司宣布开始2a期生物标志物研究的患者入组，该研究评估了用于治疗IPF的 GRI-0621。该公司的股票在过去一个月中下跌了约23％。它 创下 52 周低点 为0.2838美元。
- RSI 值：27.58
- GRI价格走势：周五，GRI Bio的股价下跌3％，收于0.3152美元。
AlloVir, Inc. (NASDAQ:ALVR)
AlloVir, Inc.（纳斯达克股票代码：ALVR）
- On Jan. 1, 2024, AlloVir board approved a reduction its workforce by approximately 95% of current employee base to reduce costs and preserve capital. The company's stock fell around 69% over the past month and has a 52-week low of $0.6230.
- RSI Value: 28.16
- ALVR Price Action: Shares of AlloVir gained 5.3% to close at $0.6950 on Friday.
- 2024年1月1日，AlloVir董事会批准将其员工队伍裁减约95％的现有员工队伍，以降低成本和保留资本。该公司的股票在过去一个月中下跌了约69％，为期52周 最低价为0.6230美元。
- RSI 值：28.16
- ALVR价格走势：周五，AlloVir的股价上涨5.3％，收于0.6950美元。
VYNE Therapeutics Inc. (NASDAQ:VYNE)
VYNE Therapeutics Inc.（纳斯达克股票代码：VYNE）
- On Nov. 13, VYNE Therapeutics posted a narrower-than-expected quarterly loss. "We have made substantial progress in advancing our business in recent months," said David Domzalski, President and Chief Executive Officer of VYNE. "With positive results from our Phase 1b trial, we believe there is strong support to advance VYN201 as a potential category-leading therapy in the treatment of vitiligo." The company's shares lost around 24% over the past month. The company's 52-week low is $2.00.
- RSI Value: 28.98
- VYNE Price Action: Shares of VYNE Therapeutics fell 2.8% to close at $2.06 on Friday.
- 11月13日，VYNE Therapeutics公布的季度亏损低于预期。VYNE总裁兼首席执行官戴维·多姆扎尔斯基表示：“最近几个月，我们在推进业务方面取得了实质性进展。”“我们的 1b 期试验取得了积极成果，我们相信推进 VYN201 成为治疗白癜风的潜在类别领先疗法得到了强有力的支持。”该公司的股价在过去一个月中下跌了约24％。该公司的52周低点为2.00美元。
- RSI 值：28.98
- VYNE价格走势：周五，VYNE Therapeutics的股价下跌2.8％，收于2.06美元。
Read More: Beat Inflation With These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
阅读更多： 用华尔街最准确的分析师提供的这3只医疗保健行业高收益股息股票战胜通胀